Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Biotechnology
Dutch thrombotic diseases specialist TargED Biopharmaceuticals has raised 39 million euros ($44 million) in a Series A financing to accelerate development of its lead compound, Microlyse. 22 February 2022
Biotechnology
Independent private equity firm dedicated to biotech and biopharma Jeito Capital today announced that it has co-led a $65 million Series A financing round in EyeBiotech Limited (EyeBio), a privately held ophthalmology biotechnology company working to deliver a new generation of therapies for eye diseases. 22 February 2022
Biotechnology
US biotech Star Therapeutics has emerged from stealth mode with $100 million in financing and the ambition to be an innovation engine for rare disease therapies. 17 February 2022
Biotechnology
Third Harmonic Bio, a US clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for treatment of severe allergy and inflammation, today launched from stealth, with the closing of a Series B financing that brings the total capital raised to date to $155 million. 16 February 2022
Biotechnology
French biopharma Aelis Farma has raised 25 million euros ($28.4 million) in an initial public offering (IPO). 16 February 2022
Generics
India's pharmaceutical sector is seeing a lot of M&A and fund-raising activity. 15 February 2022
Biotechnology
US biotechnology company Kallyope, which is focused on identifying and developing therapeutics involving the gut-brain axis, today announced the closing of a $236 million Series D financing co-led by Mubadala Investment Company and The Column Group, along with participation from other new and existing investors. 15 February 2022
Biotechnology
Canada-based companies Imagia Cybernetics, AI-healthcare company, and Canexia Health have announced their planned merger, which is expected to close at the end of February, subject to shareholder approval. 11 February 2022
Biotechnology
A biotech company called Seismic Therapeutic has launched with the aim of advancing machine learning for immunology drug development. 10 February 2022
Biotechnology
US biotech firm Ventus Therapeutics, which is developing small molecule therapeutics across a broad range of disease indications, announced today the closing of a $140 million Series C financing. 9 February 2022
Biotechnology
Orange Grove Bio, a USA-based pre-0clinical drug investment and development firm, and SV Investment, a South Korea-based venture capital and private equity firm, today announced the establishment of a new partnership through which the companies will collaborate on jointly sourcing and developing novel therapeutics in the USA and Korea. 8 February 2022
Biotechnology
A new California, USA-based biotechnology company, named Septerna, has launched today with the aim of discovering and advancing novel small molecule medicines targeting G protein-coupled receptors (GPCRs). 27 January 2022
Biotechnology
Calling MIG a leading German venture capital (VC) investment firm and one with a focus on life sciences and deep tech companies, might not do justice to the key role that it is playing in advancing some of Europe’s most promising biotech start-ups. 27 January 2022
article
In another example of the growing popularity of the SPAC merger, digital medicine company Akili Interactive is to list on the Nasdaq in this way, with the deal expected to close in mid-2022. 26 January 2022
Biotechnology
US autoimmune drug developer Kyverna Therapeutics today announced it has closed an oversubscribed $85 million Series B financing round led by Northpond Ventures. 26 January 2022
Biotechnology
US gene editing start-up Metagenomi has announced the completion of an up-sized and oversubscribed $175 million Series B financing. 26 January 2022
Biotechnology
US cell therapies maker Cellino Biotech has completed a Series A financing of $80 million, led by the impact investment arm of German pharma major Bayer – Leaps by Bayer – 8VC, and Humboldt Fund. 25 January 2022
Biotechnology
2014-founded AI specialist InstaDeep has raised $100 million in a series B funding round, led by Alpha Intelligence Capital, together with CDIB. 25 January 2022
Generics
India's domestic drug firms with active pharmaceutical ingredient (API) assets appear to be attracting interest. A case in point is Mumbai-based generic drugs manufacturer BDR Pharmaceuticals. 25 January 2022
Biosimilars
Biosimilars focussed Icelandic company Alvotech Holdings and Oaktree Acquisition Corp. II (Oaktree II), a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management, today announced $21 million in additional commitments for a private placement (PIPE) of Oaktree II common stock in connection with their proposed business combination. 19 January 2022
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Pharmaceutical
PrognomiQ has announced a series D financing round of $34 million, led by Seer, bringing the firm’s total funding to over $135 million since its founding in September 2020. 6 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze